MITCHELL DUHON: Open Payments
NPI 1982485744 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $363 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $168 |
| E.R. Squibb & Sons, L.L.C. | 6 | $121 |
| Amgen Inc. | 4 | $89 |
| Boston Scientific Corporation | 2 | $46 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: UPTRAVI, CAMZYOS, REPATHA, WATCHMAN FLX, OPSYNVI, NEXLETOL, JARDIANCE, VERQUVO.
Industry payments across LA — which companies pay providers there.
